PERCUTANEOUS CORONARY INTERVENTION (PCI)

This study is for people 65 and older who have had a stent placed to open a blocked heart artery. It compares two approaches to prevent blood clots after the procedure. One group takes two blood-thinning pills for just one week, then continues with only one. The other group takes…

This study aims to see if a structured, supervised exercise program (cardiac rehabilitation) helps the heart muscle recover and prevents long-term damage in people who have had a major heart attack treated with a stent. Researchers will enroll 100 stable patients and randomly ass…

This large study aims to compare two common procedures for treating blocked heart arteries. It will test whether using a drug-coated balloon is as safe and effective as implanting a drug-coated metal stent, especially for patients at high risk of bleeding who struggle with long-t…

This study aims to see if a new 'hybrid' treatment for long, diffuse heart artery blockages is safe and works as well as the current standard. The new approach uses a temporary, dissolving scaffold and drug-coated balloons, aiming to leave no permanent metal behind. It will be co…

This study compares two newer approaches for treating blocked heart arteries in patients aged 18-68. One uses a drug-coated balloon that leaves no permanent implant, while the other uses a temporary scaffold that dissolves over time. Researchers want to see which approach keeps a…

This large study is testing whether adding the Shexiang Baoxin Pill (MUSKARDIA) to standard care helps people who've just had a heart attack. It will involve nearly 10,000 patients who are getting a stent procedure. Researchers want to see if the pill reduces the risk of future h…

This study is testing whether a gentle electrical stimulation device worn on the ear can help reduce depression in people who have had a heart attack and a procedure to open a blocked artery. The device is non-invasive and used at home. Researchers will compare the real device to…

This study aims to understand how a low-dose anti-inflammatory drug (colchicine) changes the mix of proteins in the blood of people with coronary heart disease who still have inflammation. Researchers will compare blood samples from 176 patients, half taking the drug and half not…